By following through on Biden’s Medicare price negotiation program, he can take credit for prescription reductions. But Big Pharma doesn’t want that to happen.
Big Pharma
Posted inHealth and Social Policy
Congressional Drug-Pricing Reforms Upend Trump’s Strategy
He has typically allied with Big Pharma, pointing fingers at pharmacy benefit managers. But a bipartisan agreement could do away with that gambit.
Posted inPolitics
Dr. Strangekennedy
Or, how you should learn to worry more about illiberal politics in liberal guise
Posted inHealth and Social Policy
The Empty Hope for RFK Jr.
Taking on Big Pharma and Big Ag isn’t a one-man job.
Posted inHealth and Social Policy
FTC Sues PBMs for Jacking Up Insulin Prices
The case against Caremark, Express Scripts, and Optum Rx is the first against this element of the pharmaceutical transaction chain.
Posted inTAP
FTC Comes for PBMs
Today on TAP: An interim report shows how pharmaceutical middlemen raise drug prices and damage care.
Posted inHealth and Social Policy
New Bill Seeks to End Drug Shortages
The Senate Finance Committee wants to create a new program to incentivize better practices. Critics say there’s an easier way: end kickbacks between suppliers and bulk purchasers.
Posted inHealth and Social Policy
Our Uniquely American Drug Shortages
More drugs are in short supply than ever before. We’ve known the reason why for a long time: monopolistic middlemen.
Posted inMoney, Politics, and Power
Senators’ Latest Attempt to Enrich Big Pharma Must Not Prevail
Patents are meant to encourage actual innovation, not monster corporate profits.
Posted inHealth and Social Policy
The PBM-Insurer Mafia Comes for Community Pharmacies
UnitedHealth, CVS, and Cigna’s PBMs are using their market share and pull in Washington to drive one of the key levers to manage health care costs—independent pharmacies—out of business.